Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Berry

Showing results (521-530 of 698) with videos related to

Pageof 70
Sort By:
Hypertension (Dallas, Tex. : 1979)|June 30, 2016
Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial InfarctionJaclyn Carberry, David Carrick, Caroline Haig, et al.
Journal of the American College of Cardiology|October 17, 2009
Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studiesGanesan Karthikeyan, Ross A Moncur, Oren Levine, et al.
Journal of Cardiovascular Computed Tomography|October 10, 2022
Randomized comparison of chest pain evaluation with FFR<sub>CT</sub> or standard care: Factors determining US costsMark A Hlatky, Sam Wilding, Beth Stuart, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2023
Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapyRobert A Sykes, Karla B Neves, Rhéure Alves-Lopes, et al.
European Heart Journal|December 29, 2019
Sex associations and computed tomography coronary angiography-guided management in patients with stable chest painKenneth Mangion, Philip D Adamson, Michelle C Williams, et al.
Cost Effectiveness and Resource Allocation : C/E|November 19, 2015
Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methodsJulian Nam, Andrew Briggs, Jamie Layland, et al.
Toxicology Letters|April 27, 2021
Corrigendum to "Critique of the "Comment" etitled "Pyrethroid exposure: not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology"Frank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Structure (London, England : 1993)|February 9, 2005
dUTPase as a platform for antimalarial drug design: structural basis for the selectivity of a class of nucleoside inhibitorsJean L Whittingham, Isabel Leal, Corinne Nguyen, et al.
Cardiovascular Research|February 18, 2020
Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trialDavid Corcoran, Aleksandra Radjenovic, Ify R Mordi, et al.
Open Heart|March 23, 2025
Secular trends in types of cardiovascular disease in the West of ScotlandAnna Kamdar, Jocelyn M Friday, Tran Q B Tran, et al.
Pageof 70

Showing results (521-530 of 698) with videos related to

Sort By:
Pageof 70
Hypertension (Dallas, Tex. : 1979)|June 30, 2016
Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial InfarctionJaclyn Carberry, David Carrick, Caroline Haig, et al.
Journal of the American College of Cardiology|October 17, 2009
Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studiesGanesan Karthikeyan, Ross A Moncur, Oren Levine, et al.
Journal of Cardiovascular Computed Tomography|October 10, 2022
Randomized comparison of chest pain evaluation with FFR<sub>CT</sub> or standard care: Factors determining US costsMark A Hlatky, Sam Wilding, Beth Stuart, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2023
Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapyRobert A Sykes, Karla B Neves, Rhéure Alves-Lopes, et al.
European Heart Journal|December 29, 2019
Sex associations and computed tomography coronary angiography-guided management in patients with stable chest painKenneth Mangion, Philip D Adamson, Michelle C Williams, et al.
Cost Effectiveness and Resource Allocation : C/E|November 19, 2015
Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methodsJulian Nam, Andrew Briggs, Jamie Layland, et al.
Toxicology Letters|April 27, 2021
Corrigendum to "Critique of the "Comment" etitled "Pyrethroid exposure: not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology"Frank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Structure (London, England : 1993)|February 9, 2005
dUTPase as a platform for antimalarial drug design: structural basis for the selectivity of a class of nucleoside inhibitorsJean L Whittingham, Isabel Leal, Corinne Nguyen, et al.
Cardiovascular Research|February 18, 2020
Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trialDavid Corcoran, Aleksandra Radjenovic, Ify R Mordi, et al.
Open Heart|March 23, 2025
Secular trends in types of cardiovascular disease in the West of ScotlandAnna Kamdar, Jocelyn M Friday, Tran Q B Tran, et al.
Pageof 70